The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy
Open accessAbstract
Body composition, defined as the proportions and distribution of lean and fat tissues in the human body, is an emergent theme in clinical oncology. Severe muscle depletion (sarcopenia) is most easily overlooked in obese patients; the advent of secondary analysis of oncologic images provides a precise and specific assessment of sarcopenia. Here, we review the definitions, prevalence and clinical implications of sarcopenic obesity (SO) in medical and surgical oncology. Reported prevalence of SO varies due to the heterogeneity in the definitions and the variability in the cut points used to define low muscle mass and high fat mass. Prevalence of SO in advanced solid tumor patient populations average 9% (range 2.3%-14.6%) overall, and one in four (24.7%, range 5.9%-39.2%) patients with body mass index ≥ 30 kg/m2 are sarcopenic. SO is independently associated with higher mortality and higher rate of complications in systemic and surgical cancer treatment, across multiple cancer sites and treatment plans. These associations remain unexplained, however, it has been hypothesized that patients with sarcopenia are generally unfit and unable to tolerate stress. Another proposed mechanism relates to increased exposure to antineoplastic therapy, i.e. a large fat mass would be expected to inflate drug dose in BSA-based treatments, causing an increased rate of dose-limiting toxicity. Pharmacokinetic data are needed to confirm or refute this hypothesis. Old age, deconditioning, cancer progression, acute or chronic nonmalignant disease and drug side-effects are suggested causes of muscle loss, and it is unknown the degree to which this can be reversed. Sarcopenia can be readily detected before start of cancer treatment, however, clinical management protocols for SO patients require development. Studies of cancer treatment dose-modulation are in progress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, adverse clinical cancer outcomes reported to be relevant to SO, especially with respect to dose-limiting toxicity, surgical complications, physical disability, and shorter survival (59–61).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [59]
Citations
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 6,020
Self-citationThe Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
Bois, D. D. (1916) · Archives of Internal Medicine · doi:10.1001/archinte.1916.00080130010002 · Cited by 4,355
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Self-citationMartin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R. A., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,761
Self-citationMourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224
Self-citationShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shachar, S. S., Williams, G. R., Muss, H. B., & Nishijima, T. F. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.030 · Cited by 1,125
Understanding the mechanisms and treatment options in cancer cachexia
Fearon, K. C. H., Arends, J., & Baracos, V. E. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.209 · Cited by 952
Self-citationSarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Tan, B. H. L., Birdsell, L., Martin, L., Baracos, V. E., & Fearon, K. C. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1525 · Cited by 656
Self-citationSrikanthan, P., Hevener, A. L., & Karlamangla, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010805 · Cited by 600
Obesity and Surgical Wound Healing: A Current Review
Pierpont, Y. N., Dinh, T. P., Salas, R., Johnson, E. L., Wright, T. G., Robson, M. C., & Payne, W. G. (2014) · ISRN Obesity · doi:10.1155/2014/638936 · Cited by 480
Zhuang, C., Huang, D., Pang, W., Zhou, C.-J., Wang, S.-L., Lou, N., Ma, L., Yu, Z., & Shen, X. (2016) · Medicine · doi:10.1097/md.0000000000003164 · Cited by 471
Pamoukdjian, F., Bouillet, T., Lévy, V., Soussan, M., Zelek, L. H., & Paillaud, É. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.07.010 · Cited by 392
Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer
Dignam, J. J., Polite, B. N., Yothers, G., Raich, P. C., Colangelo, L. H., O’Connell, M. J., & Wolmark, N. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj442 · Cited by 328
Influence of body composition profile on outcomes following colorectal cancer surgery
Malietzis, G. A., Currie, A., Athanasiou, T., Johns, N., Anyamene, N. A., Glynne‐Jones, R., Kennedy, R. H., Fearon, K. C. H., & Jenkins, J. T. (2016) · British journal of surgery · doi:10.1002/bjs.10075 · Cited by 305
Levolger, S., van Vugt, J. L. A., de Bruin, R. W. F., & IJzermans, J. N. M. (2015) · British journal of surgery · doi:10.1002/bjs.9893 · Cited by 277
Lieffers, J. R. L., Mourtzakis, M., Hall, K. D., McCargar, L. J., Prado, C. M. M., & Baracos, V. E. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27273 · Cited by 251
Self-citationPecorelli, N., Carrara, G., COBELLI, F. D., Cristel, G., Damascelli, A., Balzano, G., Beretta, L., & Braga, M. (2016) · British journal of surgery · doi:10.1002/bjs.10063 · Cited by 250
Rier, H. N., Jager, A., Sleijfer, S., Maier, A. B., & Levin, M. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0066 · Cited by 233
Prado, C. M. M., Sawyer, M. B., Ghosh, S., Lieffers, J. R. L., Esfandiari, N., Antoun, S., & Baracos, V. E. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.060228 · Cited by 229
Self-citationMalietzis, G. A., Johns, N., Al-Hassi, H. O., Knight, S. C., Kennedy, R. H., Fearon, K. C. H., Aziz, O., & Jenkins, J. T. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001113 · Cited by 222
Rollins, K. E., Tewari, N., Ackner, A., Awwad, A., Madhusudan, S., Macdonald, I. A., Fearon, K. C. H., & Lobo, D. N. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.08.005 · Cited by 212
Dalal, S., Hui, D., Bidaut, L. M., Lem, K. E., Fabbro, E. D., Crane, C. H., Reyes‐Gibby, C. C., Bedi, D. G., & Bruera, E. D. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.09.010 · Cited by 186
Shen, Y., Hao, Q., Zhou, J., & Dong, B. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0569-2 · Cited by 184
Anandavadivelan, P., Brismar, T. B., Nilsson, M., Johar, A. M., & Martin, L. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.05.011 · Cited by 181
Ali, R., Baracos, V. E., Sawyer, M. B., Bianchi, L., Roberts, S., Assénat, E., Mollévi, C., & Sénesse, P. (2016) · Cancer Medicine · doi:10.1002/cam4.621 · Cited by 180
Self-citationPrado, C. M. M., Lima, I. S. F., Baracos, V. E., Bies, R. R., McCargar, L. J., Reiman, T., Mackey, J. R., Kuzma, M., Damaraju, V. L., & Sawyer, M. B. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1288-y · Cited by 165
Self-citationClinical implications of sarcopenic obesity in cancer
Carneiro, I. P., Mazurak, V. C., & Prado, C. M. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0546-5 · Cited by 162 · cited 1×
“[33] reviewed the clinical implications of SO in cancer reporting negative clinical outcomes associated with SO.”
BackgroundFabbro, E. D., Parsons, H. A., Warneke, C. L., Pulivarthi, K., Litton, J. K., Dev, R., Palla, S. L., Brewster, A. M., & Bruera, E. D. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0169 · Cited by 161
Rier, H. N., Jager, A., Sleijfer, S., van Rosmalen, J., Kock, M. C. J. M., & Levin, M.-D. (2017) · The Breast · doi:10.1016/j.breast.2016.10.014 · Cited by 149
Palmela, C., Velho, S., Agostinho, L., Branco, F., Santos, M., Santos, M. P. C., Oliveira, M. H., Strecht, J., Maio, R., Cravo, M. L., et al. (2017) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2017.17.e8 · Cited by 143
Self-citationLodewick, T. M., van Nijnatten, T. J. A., van Dam, R. M., van Mierlo, K. M. C., Dello, S. A. W. G., Neumann, U. P., Damink, S. W. M. O., & Dejong, C. H. C. (2014) · HPB · doi:10.1111/hpb.12373 · Cited by 130
Sandini, M., Bernasconi, D. P., Fior, D., Molinelli, M., Ippolito, D., Nespoli, L. C., Caccialanza, R., & Gianotti, L. V. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.002 · Cited by 130
Grotenhuis, B. A., Shapiro, J., van Adrichem, S., de Vries, M., Koek, M., Wijnhoven, B. P. L., & van Lanschot, J. J. B. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3603-1 · Cited by 110
Lou, N., Chi, C., Chen, X.-D., Zhou, C.-J., Wang, S.-L., Zhuang, C., & Shen, X. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.09.006 · Cited by 109
The advantages and limitations of cross-sectional body composition analysis
MacDonald, A. J., Greig, C. A., & Baracos, V. (2011) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e32834c49eb · Cited by 101
Self-citationImpact of Sarcopenic Obesity on Surgical Site Infection after Laparoscopic Total Gastrectomy
Nishigori, T., Tsunoda, S., Okabe, H., Tanaka, E. I., Hisamori, S., Hosogi, H., Shinohara, H., & Sakai, Y. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5385-y · Cited by 101
Cushen, S. J., Power, D. G., Murphy, K. P., McDermott, R., Griffin, B. T., Lim, M. C. J., Daly, L. E., MacEneaney, P. M., Sullivan, K. O., Prado, C. M. M., et al. (2016) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2016.04.001 · Cited by 98
Measurement of Skeletal Muscle: Laboratory and Epidemiological Methods
Evans, W. J., Heymsfield, S. B., Gallagher, D., Visser, M., Nuñez, C. E. C., & Wang, Z. M. (1995) · The Journals of Gerontology Series A · doi:10.1093/gerona/50a.special_issue.23 · Cited by 96
Heidelberger, V., Goldwasser, F., Kramkimel, N., Jouinot, A., Huillard, O., Boudou, P., Chanal, J., Arrondeau, J., Franck, N., Alexandre, J., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0464-x · Cited by 92
Relationships between body composition parameters and fluorouracil pharmacokinetics
Gusella, M., Toso, S., Ferrazzí, E., Ferrari, M., & Padrini, R. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01598.x · Cited by 90
Mei, K. L., Batsis, J. A., Mills, J. B., & Holubar, S. D. (2016) · Perioperative Medicine · doi:10.1186/s13741-016-0052-1 · Cited by 85
Advances in the Science and Application of Body Composition Measurement
Baracos, V. E., Caserotti, P., Earthman, C. P., Fields, D. A., Gallagher, D., Hall, K. D., Heymsfield, S. B., Müller, M. J., Rosen, A. N., Pichard, C., et al. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111417448 · Cited by 75
Self-citationVrieling, A., Kampman, E., Knijnenburg, N. C., Mulders, P., Sedelaar, J. P. M., Baracos, V. E., & Kiemeney, L. A. L. M. (2016) · European Urology Focus · doi:10.1016/j.euf.2016.11.009 · Cited by 71
Self-citationSjøblom, B., Benth, J. Š., Grønberg, B. H., Baracos, V. E., Sawyer, M. B., Fløtten, Ø., Hjermstad, M. J., Aass, N., & Jordhøy, M. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.09.008 · Cited by 62
Self-citationFurlanetto, J., EIERMANN, W., Marmé, F., Reimer, T., Reinisch, M., Schmatloch, S., Stickeler, E., Thomssen, C., Untch, M., Denkert, C., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw315 · Cited by 61
Heidelberger, V., Goldwasser, F., Kramkimel, N., Jouinot, A., Huillard, O., Boudou, P., Chanal, J., Arrondeau, J., Franck, N., Alexandre, J., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0475-7 · Cited by 59
Itoh, S., Yoshizumi, T., Kimura, K., Okabe, H., Harimoto, N., Ikegami, T., Uchiyama, H., Shirabe, K., Nishie, A., & Maehara, Y. (2016) · PubMed · Cited by 48
Excess baggage: sarcopenia, obesity, and cancer outcomes
Roubenoff, R. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70160-8 · Cited by 24
Flagged first, then by citations
Cited by
Sorted by citations
Bossi, P., Delrio, P., Mascheroni, A., & Zanetti, M. (2021) · Nutrients · doi:10.3390/nu13061980 · Cited by 502
Calderón‐Larrañaga, A., Vetrano, D. L., Ferrucci, L., Mercer, S. W., Marengoni, A., Onder, G., Eriksdotter, M., & Fratiglioni, L. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12843 · Cited by 442
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Reference Values for Skeletal Muscle Mass – Current Concepts and Methodological Considerations
Walowski, C. O., Braun, W., Maisch, M. J., Jensen, B., Peine, S., Norman, K., Müller, M. J., & Bosy-Westphal, A. (2020) · Nutrients · doi:10.3390/nu12030755 · Cited by 200
Sarcopenic obesity: Emerging mechanisms and therapeutic potential
Axelrod, C. L., Dantas, W. S., & Kirwan, J. P. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155639 · Cited by 204
Metadata
- Authors
- Baracos, V. E., & Arribas, L.
- Affiliations
- University of Alberta (CA)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Corresponding author
- Baracos, V.E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 29
- Issue
- suppl_2
- Pages
- ii1-ii9
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2794311213
- Cited by
- 362
- References
- 51
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 41 · 2023: 55 · 2022: 54 · 2021: 56 · 2020: 41 · 2019: 25 · 2018: 13
- FWCI
- 23.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Keywords
- sarcopenic obesity, sarcopenia, obesity, muscle atrophy, body composition, cancer treatment complications, survival, dose-limiting toxicity, antineoplastic therapy, body mass index, pharmacokinetics, surgical oncology, medical oncology
- MeSH terms
- Antineoplastic Agents, Body Composition, Clinical Trials as Topic, Humans, Neoplasms, Obesity, Postoperative Complications, Surgical Procedures, Operative, Body Mass Index, Prevalence, Survival Analysis, Muscle, Skeletal, Neoadjuvant Therapy, Sarcopenia, Chemoradiotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
